Muscle Loss Over Time and Lean Muscle Mass

In this episode, we delve into the complex relationship between sarcopenia and GLP-1 receptor agonists (GLP-1 RAs). Sarcopenia, characterized by the loss of muscle mass and function, can lead to muscle tissue becoming fatty, which poses a significant risk for developing diabetes. We explore how GLP-1 RAs, commonly used in diabetes management, might influence muscle composition and potentially mitigate some risks associated with sarcopenia. This discussion is crucial for understanding the broader implications of muscle health in metabolic diseases.